×
For best experience we recommend to activate Javascript in your browser.
SIPA1L2 antibody (AA 522-778) (HRP)
The HRP-conjugated Rabbit Polyclonal anti-SIPA1L2 antibody (ABIN7169698) specifically detects SIPA1L2 in ELISA.
The antibody is reactive with Human samples.
Catalog No. ABIN7169698
$394.68
Plus shipping costs $50.00
50 μg ABIN7360439
100 μg ABIN7169698
50 μg ABIN7360439
100 μg ABIN7169698
Delivery in 13 to 17 Business Days
Quick Overview for SIPA1L2 antibody (AA 522-778) (HRP) (ABIN7169698)
Target
SIPA1L2
(Signal-Induced Proliferation-Associated 1 Like 2 (SIPA1L2))
Reactivity
All reactivities for SIPA1L2 antibodies
Human
Host
All hosts for SIPA1L2 antibodies
Rabbit
Clonality
All clonalities for SIPA1L2 antibodies
Polyclonal
Conjugate
All conjugates for SIPA1L2 antibodies
This SIPA1L2 antibody is conjugated to HRP
Application
All applications for SIPA1L2 antibodies
ELISA
Product Details anti-SIPA1L2 Antibody (HRP)
(hide)
Binding Specificity
All epitopes for SIPA1L2 antibodies
AA 522-778
Purpose
SIPA1L2 Antibody, HRP conjugated
Purification
Protein G purified
Purity
>95 %
Immunogen
Recombinant Human Signal-induced proliferation-associated 1-like protein 2 protein (522-778AA)
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Preservative: 0.03 % Proclin 300 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C,-80 °C
Storage Comment
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Target Details for SIPA1L2
(hide)
Target
SIPA1L2
(Signal-Induced Proliferation-Associated 1 Like 2 (SIPA1L2))
Alternative Name
SIPA1L2
Background
SIPA1L2 antibody, KIAA1389 antibody, Signal-induced proliferation-associated 1-like protein 2 antibody, SIPA1-like protein 2 antibody
UniProt
Q9P2F8
Recently viewed
(hide)
Chat with us , powered by LiveChat